Q · NYSE
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Total Revenue | $4.75B | $4.33B | $4.04B |
| Cost of Revenue | $2.56B | $2.34B | $2.28B |
| Research & Development | $354.00M | $314.00M | $303.00M |
| Selling, General & Administrative | $620.00M | $603.00M | $533.00M |
| Other Income / (Expense) | $11.00M | $25.00M | $11.00M |
| Income Before Taxes | $962.00M | $901.00M | $632.00M |
| Provision for Income Taxes | $233.00M | $177.00M | $99.00M |
| Net Income | $729.00M | $724.00M | $533.00M |
| Basic EPS | $3.30 | $3.31 | $2.42 |
| Diluted EPS | $3.30 | $3.31 | $2.42 |
| Basic Shares Outstanding | 209.60M | 209.40M | 209.40M |
| Diluted Shares Outstanding | 209.80M | 209.40M | 209.40M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $4.50 | $4.40 | $4.60 | 1 | ↑0 ↓0 |
| Dec 2027 | $4.87 | $4.67 | $5.15 | 4 | ↑2 ↓0 |
| Dec 2028 | $5.75 | $5.66 | $5.84 | 2 | ↑1 ↓0 |
| Dec 2029 | $6.53 | $6.53 | $6.53 | 1 | ↑0 ↓0 |
